Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Clinical Subtype | Transcriptional Subtype | Small Molecule | Antibody | Perturbagen Target | Perturbagen Class | Perturbagen Concentration | Perturbagen Conc Unit | Biological Replicate ID | Relative Cell Count | Normalized Growth Rate Inhibition Value | Nominal Division Rate |
---|---|---|---|---|---|---|---|---|---|---|---|---|
184A1 | NM | Basal | Pemetrexed | TYMS/DHFR/GARFT | TYMS | 117 | uM | 5895.095 | 0.3334 | -0.0561 | 1.4629 | |
184A1 | NM | Basal | Pemetrexed | TYMS/DHFR/GARFT | TYMS | 585 | uM | 5895.095 | 0.3541 | -0.0165 | 1.4629 | |
184A1 | NM | Basal | Pemetrexed | TYMS/DHFR/GARFT | TYMS | 2920 | uM | 5895.095 | 0.3946 | 0.0591 | 1.4629 | |
184B5 | NM | Basal | Pemetrexed | TYMS/DHFR/GARFT | TYMS | 0.00749 | uM | 5896.095 | 0.9589 | 0.9467 | 1.5532 | |
184B5 | NM | Basal | Pemetrexed | TYMS/DHFR/GARFT | TYMS | 0.0374 | uM | 5896.095 | 0.9593 | 0.9472 | 1.5532 | |
184B5 | NM | Basal | Pemetrexed | TYMS/DHFR/GARFT | TYMS | 0.187 | uM | 5896.095 | 0.7220 | 0.6217 | 1.5532 | |
184B5 | NM | Basal | Pemetrexed | TYMS/DHFR/GARFT | TYMS | 0.936 | uM | 5896.095 | 0.2987 | -0.0813 | 1.5532 | |
184B5 | NM | Basal | Pemetrexed | TYMS/DHFR/GARFT | TYMS | 4.68 | uM | 5896.095 | 0.2340 | -0.2149 | 1.5532 | |
184B5 | NM | Basal | Pemetrexed | TYMS/DHFR/GARFT | TYMS | 23.4 | uM | 5896.095 | 0.1870 | -0.3204 | 1.5532 | |
184B5 | NM | Basal | Pemetrexed | TYMS/DHFR/GARFT | TYMS | 117 | uM | 5896.095 | 0.1824 | -0.3313 | 1.5532 | |
184B5 | NM | Basal | Pemetrexed | TYMS/DHFR/GARFT | TYMS | 585 | uM | 5896.095 | 0.2029 | -0.2838 | 1.5532 | |
184B5 | NM | Basal | Pemetrexed | TYMS/DHFR/GARFT | TYMS | 2920 | uM | 5896.095 | 0.2453 | -0.1907 | 1.5532 | |
184B5 | NM | Basal | Pemetrexed | TYMS/DHFR/GARFT | TYMS | 0.00749 | uM | 5897.095 | 1.0016 | 1.0026 | 1.2197 | |
184B5 | NM | Basal | Pemetrexed | TYMS/DHFR/GARFT | TYMS | 0.0374 | uM | 5897.095 | 0.9995 | 0.9992 | 1.2197 | |
184B5 | NM | Basal | Pemetrexed | TYMS/DHFR/GARFT | TYMS | 0.187 | uM | 5897.095 | 0.9465 | 0.9119 | 1.2197 | |
184B5 | NM | Basal | Pemetrexed | TYMS/DHFR/GARFT | TYMS | 0.936 | uM | 5897.095 | 0.4924 | 0.1188 | 1.2197 | |
184B5 | NM | Basal | Pemetrexed | TYMS/DHFR/GARFT | TYMS | 4.68 | uM | 5897.095 | 0.2952 | -0.2645 | 1.2197 | |
184B5 | NM | Basal | Pemetrexed | TYMS/DHFR/GARFT | TYMS | 23.4 | uM | 5897.095 | 0.2640 | -0.3288 | 1.2197 | |
184B5 | NM | Basal | Pemetrexed | TYMS/DHFR/GARFT | TYMS | 117 | uM | 5897.095 | 0.2447 | -0.3694 | 1.2197 | |
184B5 | NM | Basal | Pemetrexed | TYMS/DHFR/GARFT | TYMS | 585 | uM | 5897.095 | 0.2665 | -0.3237 | 1.2197 | |
184B5 | NM | Basal | Pemetrexed | TYMS/DHFR/GARFT | TYMS | 2920 | uM | 5897.095 | 0.3078 | -0.2389 | 1.2197 | |
600MPE | HR+ | Luminal | Pemetrexed | TYMS/DHFR/GARFT | TYMS | 0.00749 | uM | 5898.095 | 0.7422 | 0.3043 | 0.6975 | |
600MPE | HR+ | Luminal | Pemetrexed | TYMS/DHFR/GARFT | TYMS | 0.0374 | uM | 5898.095 | 0.7260 | 0.2638 | 0.6975 | |
600MPE | HR+ | Luminal | Pemetrexed | TYMS/DHFR/GARFT | TYMS | 0.187 | uM | 5898.095 | 0.7410 | 0.3014 | 0.6975 | |
600MPE | HR+ | Luminal | Pemetrexed | TYMS/DHFR/GARFT | TYMS | 0.936 | uM | 5898.095 | 0.7325 | 0.2800 | 0.6975 |